▶ 調査レポート

HER2陰性乳癌治療の世界市場:市場規模・現状・予測

• 英文タイトル:Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。HER2陰性乳癌治療の世界市場:市場規模・現状・予測 / Global HER2-negative breast cancer Treatment Market Size, Status and Forecast 2019-2025 / QYR9ST04474資料のイメージです。• レポートコード:QYR9ST04474
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※当調査レポートでは、HER2陰性乳癌治療の世界市場について調査・分析し、HER2陰性乳癌治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(化学療法、手術、放射線、ホルモン療法/内分泌療法)、用途別(病院、診療所)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のHER2陰性乳癌治療市場動向
・主要企業別マーケットシェア
・HER2陰性乳癌治療の種類別市場規模2014-2019
(化学療法、手術、放射線、ホルモン療法/内分泌療法)
・HER2陰性乳癌治療の用途別市場規模2014-2019
(病院、診療所)
・HER2陰性乳癌治療の北米市場:主要企業・種類別/用途別市場規模
・HER2陰性乳癌治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・HER2陰性乳癌治療の中国市場:主要企業・種類別/用途別市場規模
・HER2陰性乳癌治療の日本国内市場:主要企業・種類別/用途別市場規模
・HER2陰性乳癌治療の東南アジア市場:主要企業・種類別/用途別市場規模
・HER2陰性乳癌治療のインド市場:主要企業・種類別/用途別市場規模
・HER2陰性乳癌治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Pfizer、Novartis、Pfizer、GlaxoSmithKline、Novartis、Merck、Eli Lilly)
・HER2陰性乳癌治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...

HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.In 2018, the global HER2-negative breast cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global HER2-negative breast cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HER2-negative breast cancer Treatment development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Pfizer
Novartis
Pfizer
GlaxoSmithKline
Novartis
Merck
Eli Lilly

Market segment by Type, the product can be split into
Chemotherapy
Surgery
Radiation
Hormonal therapy/endocrine therapy

Market segment by Application, split into
Hosptial
Clinic

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global HER2-negative breast cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the HER2-negative breast cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of HER2-negative breast cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global HER2-negative breast cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation
1.4.5 Hormonal therapy/endocrine therapy
1.5 Market by Application
1.5.1 Global HER2-negative breast cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hosptial
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 HER2-negative breast cancer Treatment Market Size
2.2 HER2-negative breast cancer Treatment Growth Trends by Regions
2.2.1 HER2-negative breast cancer Treatment Market Size by Regions (2014-2025)
2.2.2 HER2-negative breast cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 HER2-negative breast cancer Treatment Market Size by Manufacturers
3.1.1 Global HER2-negative breast cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global HER2-negative breast cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global HER2-negative breast cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 HER2-negative breast cancer Treatment Key Players Head office and Area Served
3.3 Key Players HER2-negative breast cancer Treatment Product/Solution/Service
3.4 Date of Enter into HER2-negative breast cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global HER2-negative breast cancer Treatment Market Size by Type (2014-2019)
4.2 Global HER2-negative breast cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States HER2-negative breast cancer Treatment Market Size (2014-2019)
5.2 HER2-negative breast cancer Treatment Key Players in United States
5.3 United States HER2-negative breast cancer Treatment Market Size by Type
5.4 United States HER2-negative breast cancer Treatment Market Size by Application

6 Europe
6.1 Europe HER2-negative breast cancer Treatment Market Size (2014-2019)
6.2 HER2-negative breast cancer Treatment Key Players in Europe
6.3 Europe HER2-negative breast cancer Treatment Market Size by Type
6.4 Europe HER2-negative breast cancer Treatment Market Size by Application

7 China
7.1 China HER2-negative breast cancer Treatment Market Size (2014-2019)
7.2 HER2-negative breast cancer Treatment Key Players in China
7.3 China HER2-negative breast cancer Treatment Market Size by Type
7.4 China HER2-negative breast cancer Treatment Market Size by Application

8 Japan
8.1 Japan HER2-negative breast cancer Treatment Market Size (2014-2019)
8.2 HER2-negative breast cancer Treatment Key Players in Japan
8.3 Japan HER2-negative breast cancer Treatment Market Size by Type
8.4 Japan HER2-negative breast cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia HER2-negative breast cancer Treatment Market Size (2014-2019)
9.2 HER2-negative breast cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia HER2-negative breast cancer Treatment Market Size by Type
9.4 Southeast Asia HER2-negative breast cancer Treatment Market Size by Application

10 India
10.1 India HER2-negative breast cancer Treatment Market Size (2014-2019)
10.2 HER2-negative breast cancer Treatment Key Players in India
10.3 India HER2-negative breast cancer Treatment Market Size by Type
10.4 India HER2-negative breast cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America HER2-negative breast cancer Treatment Market Size (2014-2019)
11.2 HER2-negative breast cancer Treatment Key Players in Central & South America
11.3 Central & South America HER2-negative breast cancer Treatment Market Size by Type
11.4 Central & South America HER2-negative breast cancer Treatment Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 HER2-negative breast cancer Treatment Introduction
12.1.4 AstraZeneca Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 HER2-negative breast cancer Treatment Introduction
12.2.4 Bristol-Myers Squibb Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 HER2-negative breast cancer Treatment Introduction
12.3.4 Eli Lilly Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 HER2-negative breast cancer Treatment Introduction
12.4.4 Pfizer Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 HER2-negative breast cancer Treatment Introduction
12.5.4 Novartis Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 HER2-negative breast cancer Treatment Introduction
12.6.4 Pfizer Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Company Details
12.7.2 Company Description and Business Overview
12.7.3 HER2-negative breast cancer Treatment Introduction
12.7.4 GlaxoSmithKline Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.7.5 GlaxoSmithKline Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 HER2-negative breast cancer Treatment Introduction
12.8.4 Novartis Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 HER2-negative breast cancer Treatment Introduction
12.9.4 Merck Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Company Details
12.10.2 Company Description and Business Overview
12.10.3 HER2-negative breast cancer Treatment Introduction
12.10.4 Eli Lilly Revenue in HER2-negative breast cancer Treatment Business (2014-2019)
12.10.5 Eli Lilly Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table HER2-negative breast cancer Treatment Key Market Segments
Table Key Players HER2-negative breast cancer Treatment Covered
Table Global HER2-negative breast cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global HER2-negative breast cancer Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Figures
Table Key Players of Radiation
Figure Hormonal therapy/endocrine therapy Figures
Table Key Players of Hormonal therapy/endocrine therapy
Table Global HER2-negative breast cancer Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hosptial Case Studies
Figure Clinic Case Studies
Figure HER2-negative breast cancer Treatment Report Years Considered
Table Global HER2-negative breast cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global HER2-negative breast cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global HER2-negative breast cancer Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global HER2-negative breast cancer Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global HER2-negative breast cancer Treatment Market Share by Regions 2014-2019
Figure Global HER2-negative breast cancer Treatment Market Share by Regions 2014-2019
Figure Global HER2-negative breast cancer Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global HER2-negative breast cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global HER2-negative breast cancer Treatment Market Share by Manufacturers (2014-2019)
Figure Global HER2-negative breast cancer Treatment Market Share by Manufacturers in 2018
Table Global HER2-negative breast cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players HER2-negative breast cancer Treatment Product/Solution/Service
Table Date of Enter into HER2-negative breast cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global HER2-negative breast cancer Treatment Market Size Share by Type (2014-2019)
Figure Global HER2-negative breast cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global HER2-negative breast cancer Treatment Market Size Share by Application (2014-2019)
Figure Global HER2-negative breast cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global HER2-negative breast cancer Treatment Revenue Market Share by Application in 2018
Figure United States HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table United States HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table United States HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table United States HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table United States HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Figure Europe HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table Europe HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table Europe HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Figure China HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table China HER2-negative breast cancer Treatment Market Size by Type (2014-20189) (Million US$)
Table China HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table China HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table China HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Figure Japan HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table Japan HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table Japan HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Figure Southeast Asia HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table Southeast Asia HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table Southeast Asia HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Figure India HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table India HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table India HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table India HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table India HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Figure Central & South America HER2-negative breast cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players HER2-negative breast cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players HER2-negative breast cancer Treatment Market Share (2018-2019)
Table Central & South America HER2-negative breast cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America HER2-negative breast cancer Treatment Market Share by Type (2014-2019)
Table Central & South America HER2-negative breast cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America HER2-negative breast cancer Treatment Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in HER2-negative breast cancer Treatment Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in HER2-negative breast cancer Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in HER2-negative breast cancer Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Global HER2-negative breast cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global HER2-negative breast cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global HER2-negative breast cancer Treatment Market Size Share by Regions in 2025
Figure United States HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America HER2-negative breast cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global HER2-negative breast cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global HER2-negative breast cancer Treatment Market Size by Product (2019-2025)
Figure Global HER2-negative breast cancer Treatment Market Size by Product in 2025
Table Global HER2-negative breast cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global HER2-negative breast cancer Treatment Market Size by Application (2019-2025)
Figure Global HER2-negative breast cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources